Keywords: genentech, dnase, study, completed, its, phase, iii

GENENTECH DNase STUDY COMPLETED

Article | 07 December 1992

Print This

Genentech has completed its Phase III study of Pulmozyme (recombinant DNase) in the treatment of cystic fibrosis. The results of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in